CAR Gene Delivery by T‐cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms

Abstract Lentiviral vectors (LV) have become the dominant tool for stable gene transfer into lymphocytes including chimeric antigen receptor (CAR) gene delivery to T cells, a major breakthrough in cancer therapy. Yet, room for improvement remains, especially for the latest LV generations delivering...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Filippos T Charitidis, Elham Adabi, Naphang Ho, Angela H Braun, Ciara Tierney, Lisa Strasser, Frederic B Thalheimer, Liam Childs, Jonathan Bones, Colin Clarke, Christian J Buchholz
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2023-12-01
Serie:	Advanced Science
Soggetti:	CAR T cells IFITM in vivo gene delivery rapamycin receptor‐targeted vectors transduction enhancer
Accesso online:	https://doi.org/10.1002/advs.202302992
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!